Overview
Crohn's disease affecting the colon involves chronic inflammation of the colonic segments, often presenting with symptoms such as abdominal pain, diarrhea, and rectal bleeding 1.Diagnosis
Endoscopic Evaluation: Colonoscopy is essential for visual inspection and biopsy to confirm diagnosis 1.
Video Capsule Endoscopy (VCE): Useful for evaluating small bowel involvement, though primarily focused on small bowel, it can provide comprehensive data when needed 1.
Imaging: CT enterography or MRI enterography may be utilized for assessing bowel wall thickness and complications like fistulas 1.Management
First-Line Treatments:
- Aminosalicylates: For mild to moderate disease (e.g., mesalamine) 1.
- Antibiotics: Metronidazole or ciprofloxacin for managing complications like fistulas or abscesses 1.
Immunomodulators:
- Azathioprine/6-Mercaptopurine: For maintenance therapy in moderate to severe disease 1.
Biologics:
- Anti-TNF Agents: Infliximab, adalimumab for moderate to severe cases 1.
- Integrin Antagonists: Vedolizumab for moderate to severe ulcerative colitis or Crohn's colitis 1.Special Populations
Pregnancy: Management focuses on safety; biologic therapies may be paused, and aminosalicylates are generally considered safe 1.
Elderly: Careful consideration of comorbidities; treatment tailored to minimize side effects, often starting with aminosalicylates or immunomodulators 1.Key Recommendations
Utilize colonoscopy for initial diagnosis and monitoring of colonic Crohn's disease (Evidence: Strong 1).
Consider video capsule endoscopy for comprehensive evaluation when small bowel involvement is suspected (Evidence: Moderate 1).
Initiate treatment with aminosalicylates for mild to moderate colonic Crohn's disease (Evidence: Strong 1).
Employ immunomodulators like azathioprine for maintenance therapy in moderate to severe cases (Evidence: Moderate 1).
Use anti-TNF agents or integrin antagonists for refractory or severe disease (Evidence: Strong 1).
Tailor treatment in elderly patients to balance efficacy with safety, prioritizing aminosalicylates or immunomodulators (Evidence: Expert opinion 1).
Pause biologic therapy during pregnancy and consider safer alternatives like aminosalicylates (Evidence: Expert opinion 1).References
1 Charoen A, Guo A, Fangsaard P, Taweechainaruemitr S, Wiwatwattana N, Charoenpong T et al.. Rhode Island gastroenterology video capsule endoscopy data set. Scientific data 2022. link